Related Experiment Video
Updated: Jun 13, 2025

07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
6.4K
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Ludovica Arpinati1, Giulia Carradori1, Ruth Scherz-Shouval2
1Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Nature Reviews. Cancer
|September 9, 2024
Summary
Solid tumours involve complex interactions within the tumour microenvironment (TME). Cancer-associated fibroblasts (CAFs) remodel the extracellular matrix (ECM), impacting T cell function and cancer progression, suggesting ECM targeting for therapies.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Solid tumours are complex ecosystems involving cancer cells, immune cells, and stromal components.
- The tumour microenvironment (TME) critically influences tumour progression and metastasis.
- Cancer-associated fibroblasts (CAFs) and the extracellular matrix (ECM) are key regulators within the TME.
Purpose of the Study:
- To review the intricate crosstalk between cancer cells, CAFs, and immune cells within the TME.
- To elucidate the role of CAF-mediated ECM remodeling in modulating anti-tumour immunity, particularly T cell functions.
- To explore the therapeutic potential of targeting ECM components for improved cancer treatment strategies.
Main Methods:
- Literature review of studies investigating TME composition and function.
- Analysis of non-cell-autonomous signaling pathways involving CAFs and ECM.
- Synthesis of current research on the impact of ECM remodeling on immune cell activity.
Main Results:
- CAFs significantly influence the TME by secreting and remodeling the ECM.
- CAF-induced ECM changes can impair T cell infiltration and function, promoting immune evasion.
- Non-cell-autonomous signaling mediated by ECM components is crucial for cancer progression.
Conclusions:
- Targeting CAF-driven ECM remodeling presents a promising therapeutic avenue.
- Modulating the ECM could enhance the efficacy of immunotherapies by restoring T cell function.
- Understanding TME crosstalk is essential for developing novel and effective cancer treatments.

